1904 Tower Plaza, Sheikh Zayed Road, opp. The Future Museum, Dubai, UAE
business@hawklandglobalfz.com
Feasibility planning for a plastic-bottle IV manufacturing facility, bringing production, utilities, cleanrooms and engineering into one coordinated plant concept.
The Aqua Pure project demonstrates how Hawkland structures a sterile IV manufacturing facility at the feasibility stage, allowing key technical and layout decisions to be evaluated before construction or procurement begins.
A pharmaceutical group in Pakistan wanted to plan a facility for large-volume IV fluids in plastic bottles. Before committing capital, the plant needed to be sized, organised and evaluated against GMP expectations.
Hawkland's feasibility proposal compared an expanded plant layout designed for future production lines with a compact two-storey alternative that reduces land use while increasing finished-goods capacity.
The proposal was developed around EU Annex 1, WHO TRS 1044 principles and Pakistan DRAP GMP requirements, integrating production, utilities, personnel flow and controlled cleanroom environments.
The study combines the manufacturing line and the supporting facility infrastructure instead of treating each system as an isolated package.
Expanded and compact layouts were compared for the same project site.
Injection stretch blow molding and blow-fill-seal technologies were incorporated into the feasibility study.
Sterilisation planning was integrated with automated product inspection.
WFI generation, storage and distribution were included in the utility planning.
Controlled areas were organised using a defined cleanroom zoning and pressure-cascade strategy.
Step-by-step personnel gowning and movement were considered within the proposed layout.
Equipment lists, engineering drawings and an unpriced bill of quantities supported the feasibility proposal.
URS development, equipment selection, commissioning, validation, training and after-sales support form the wider Hawkland delivery methodology.
The feasibility concept creates a logical route from pharmaceutical water and raw materials through sterile production and final packaging.
The proposal separates production activities into controlled zones and establishes increasing positive pressure toward the most critical sterile areas.
Hawkland structures IV projects through a defined sequence, connecting technical planning with equipment, validation and long-term support.
The same early-stage questions apply to pharmaceutical manufacturers planning IV production across Africa: capacity, layout, GMP requirements, skills and long-term scalability.
Establish a defined technical route for producing IV fluids locally.
Compare facility layouts against real production and volume requirements.
Plan cleanrooms, utilities and qualification before construction begins.
Build training and technology transfer into the project scope.
Create room for expansion and technical support beyond commissioning.
Hawkland Global supports pharmaceutical manufacturers from feasibility and technical planning through equipment integration, commissioning, validation and training.